Complication of Hemodialysis
Conditions
Keywords
hemodialysis, dialysate and serum sodium
Brief summary
A difference between dialysate and serum sodium concentration leads to diffusive sodium transfer across the dialyzer membrane. The consequences of diffusive sodium flux into the patient can be chronic sodium overload leading to overhydration, hypertension, cardiovascular disease, and other problems. Diffusive sodium flux out of the patient can lead to intradialytic blood pressure instability. A simple strategy for alignment of dialysate and serum sodium concentrations was implemented starting in April/May 2010 in order to minimize the problems particularly associated with chronic sodium overload.
Detailed description
The purpose of this database analysis is to assess the impact that this operational change has had in the short, medium and long term on key clinical and laboratory parameters in the patients, including blood pressure, body weight, interdialytic weight gain, serum electrolytes, intradialytic saline administration, missed treatments, hospitalizations, medication, inflammatory markers, etc. All subjects included in the final dataset will be matched with dialysis patients receiving treatment in other dialysis clinics of the Renal Research Institute who were not subject to the operational change. This will lead to the development of a matched cohort of equal size unexposed to dialysate to serum sodium alignment. The analysis is planned to investigate treatment effects, and test the effects of dialysate to serum sodium alignment for interactions and associations between those laboratory and clinical parameters. The extent and magnitude of sodium alignment (the operational change) will also be assessed.
Interventions
Sponsors
Study design
Eligibility
Inclusion criteria
* Subjects on hemodialysis
Exclusion criteria
* None
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Interdialytic weight gain | Each dialysis treatment (3x per week) - 2 years of treatment data |
| Pre-dialysis Blood Pressure | Each dialysis treatment (3x per week)- 2 years of treatment data |
Secondary
| Measure | Time frame |
|---|---|
| Hospitalization rate and number of days | Per occurence during the entire follow-up period of 2 years |
Other
| Measure | Time frame |
|---|---|
| Inflammatory markers | Each treatment (3x per week)- 2 years of treatment data |
| Body weight | Each treatment (3x per week)- 2 years of treatment data |
| Missed treatments | Per occurance |
| Medications | Per occurance |
| Serum electrolytes | Each treatment (3x per week)- 2 years of treatment data |
| Intradialytic saline administration | Per occurance |
Countries
United States